The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. In 2024, the FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia Cavazzoni, M.D., stepped down in January and joined Pfizer’s C-suite as chief medical officer.
The two were German immigrants and chemists that set up shops outside New York City to make medicinal compounds. The first major success was an antiparasitic called santonin, and the commercialization of citric acid-making technologies quickly followed that up. Their success with citric acid led to the company’s expansion and other major discoveries. Discover which analysts rank highest on predicting the price target of PFE. On Oct. 29, 2021, the FDA extended the EUA for the vaccine to include children ages 5–11.
PFE chart
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE.
GSK & PFE’s RSV Vaccines Recommended for Use in Adults Aged 50-59
2021 highlights include 8 FDA approvals, four new regulatory submissions and 13 new trial startups. Pfizer is also a well-known dividend payer and has returned more than $8.7 billion to shareholders since going public. Albert Bourla is the pharmaceutical giant’s current chief executive officer (CEO). Pfizer is classified as a member of the S&P 500 healthcare sector and operates within the biotechnology and pharmaceutical industry.
Premium Investing Services
There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for a deeply undervalued AI stock that is more promising than PFE but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. Pfizer (PFE 0.43%) recently reminded investors how risky the drug-development business can be. On April 14, the company told investors it would scrap development of danuglipron, its oral GLP-1 candidate for weight management.
PFE price to earnings (PE)
Enter your email address and below to see which companies made the list. Pfizer scored higher than 100% of companies evaluated by MarketBeat, and ranked 3rd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Pfizer Inc was incorporated on June 2nd, 1942 in Delaware, and another period of expansion began. The postwar drop in demand for penicillin led to the discovery of newer, more marketable antibiotics and cemented the company’s role in modern medicine.
- According to the company, it discontinued development after just one patient in a dose-optimization study experienced a liver injury that could have been caused by the experimental GLP-1 pill.
- The monthly returns are then compounded to arrive at the annual return.
- Discover which analysts rank highest on predicting the price target of PFE.
- The end of Pfizer’s danuglipron program highlights just how risky the drug-development process can be.
For valuing profitable companies with growth potential
- Stocks with high Zacks Ranks and “A” grades for Value will be some of the highest-quality value stocks on the market today.
- This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company’s expected earnings growth rate.
- Many investors expect pharmaceutical industry lobbyists to prevent the Trump administration from rendering CDER incapable of reviewing new drug applications at its usual pace.
- Zacks Ranks stocks can, and often do, change throughout the month.
Pfizer is also working on a once-a-day version of its weight-loss pill – danuglipron – and scrapped a twice-daily version of the drug late last year, amid high rate of side effects. The company’s top seller in 2021 was Comirnaty, a COVID-19 vaccine. It generated nearly $37 billion in 2021 and was followed by Prevnar, Ibrance and Eliquis with just over $5 billion in sales each. Other blockbuster names on Pfizer’s list include Xeljanz and Enbrel, each bringing in $3.5 billion. Pfizer operates 39 research and production facilities worldwide and sells its products in 125 countries.
On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the “Value” category. Stocks with high Zacks Ranks and “A” grades for Value will be some of the highest-quality value stocks on the market today. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer.
The biopharma has a robust pipeline with potential mega blockbuster cancer drugs a… If the firm warns that there can be a possibility to see smaller profits, the stock tends to fall. This might happen across the market, but there is a silver lining. As per Morningstar chief research and investment officer Dan Kemp, it is important to note that most of the value lies in the future. Therefore, the impact on the company’s real value is expected to be muted. According to him, widening of the gap between stock prices and future real values can be a very fertile soil for the market investors.
Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. bdswiss forex broker review Zacks Ranks stocks can, and often do, change throughout the month.
Albert Bourla, who has been with Pfizer for more than 25 years, is currently the company’s chief executive officer (CEO) and chairman. Before assuming the CEO position in January 2019, he was chief operating officer (COO) starting in January 2018. From February 2016 to December 2018, Bourla was group president of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business. He was president and general manager of the company’s Established Products business from 2010 to 2013. Bourla served in a number of other roles from 1993, when he joined the company, to 2010.
Inc. (MRK), Switzerland-based Roche Holding AG (RHHBY), and Eli Lilly and Co. (LLY). Pfizer reported adjusted net income attributable to its common shareholders of $25.2 billion on $81.3 billion in annual revenue in its how to research old company stocks for free 2021 fiscal year (FY). The company traces its origins to the founding of Charles Pfizer & Co. in Brooklyn, N.Y., in 1849 by Charles Pfizer and Charles Erhart. The company expanded during the late 1800s and early 1900s, remaining a privately held company until June 1942, when it offered shares of its common stock to the public for the first time.
Falling sales clubbed with lower margin has weighed on Pfizer’s bottom line over the recent years. Trump doubled down on plans to soon impose “major” pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter. Sign-up to receive the latest news and ratings for Pfizer and its competitors with MarketBeat’s FREE daily newsletter. World War I caused a shortage of materials for making citric acid and forced the company to seek alternatives. The one they latched on to was the fermentation of certain fungi known to produce citric acid naturally. This led to the advancement of fermentation technology that was later used in the commercial production of penicillin and then the advancement of antibiotics in general.
Morningstar, while quoting FactSet’s consensus estimates, mentioned that analysts expect 6.8% earnings growth in Q1 for companies in the S&P 500 benchmark index. Goldman Sachs highlighted that equities around the world traded in and out of a bear market — which is often defined as a 20% decline from the recent peak. According to Peter Oppenheimer, chief global equity strategist at Goldman Sachs Research, the history of bear markets can provide some clues regarding the duration and severity of such downturns. U.S. stocks ended significantly higher after Trump announced his decision to put a 90-day pause on the additional country-specific portion of the reciprocal tariffs.
Investors have punished PFE stock lately, amid declining revenue and margins. An activist investor – Starboard – built a $1 billion position in PFE stock a few months back, and it has stated that Pfizer has overspent on its recent acquisitions. Furthermore, Pfizer has withdrawn the sickle cell disease candidate it acquired in a $5.4 billion deal with Global Blood Therapeutics, raising concerns over management’s decisions on R&D spending. President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum.
(0.18%), Rhumbline Advisers (0.17%), Fifth Third Bancorp (0.05%) and Wealth Enhancement Advisory Services LLC (0.05%). Insiders that own company stock include Pfizer Inc, William R Carapezzi Jr, Ronald E Blaylock, Jennifer B Damico and Scott Gottlieb. Pfizer Inc. was founded in 1849 by Charles Pfizer Sr. and his cousin Charles Earhart.
Nvidia (NVDA) says it will make it the first artificial intelligence (AI) supercomputer in the US, marking heavy investment in the US while President Trump imposes hefty tariffs on foreign imports. Intel (INTC) sells its controlling stake in Altera to Silver Lake. To watch more expert insights and analysis on the engulfing candle strategy latest market action, check out more Morning Brief here. Tariffs can impact the corporate bottom lines in several ways, both directly and indirectly. Notably, the increased import costs put more pressure on the margins. While some firms can decide to alleviate the pressure by increasing the prices for customers, others can choose to absorb them, says the firm.
